We are thrilled to introduce the launch of the EU-funded project HYDROHEAL, which recently occurred in Valencia. Attending from Asphalion were Montse Domingo, Elisa Jiménez, and Cristina Ameixeras. HYDROHEAL aims to transform fracture treatment with cutting-edge hydrogel formulations designed to overcome the constraints of existing methods used for treating vertebral and alveolar fractures.
Bone atrophy and fractures, often due to trauma, infections, osteoporosis, or cancer pose significant global health challenges. Traditional treatments using cement and bone grafts have their drawbacks, including risks associated with synthetic polymers like polymethyl methacrylate, which can lead to leakage, spinal complications, and inadequate healing.
The HYDROHEAL project aims to overcome these challenges by developing safe, sustainable, and cost-effective hydrogel formulations using renewable biomaterials. These formulations align with the EU Circular Economy Action Plan and the Chemicals Strategy for Sustainability. These self-solidifying hydrogels release active pharmaceutical ingredients upon external stimulation, potentially improving treatment efficacy, preventing infections, and accelerating fracture healing.
Asphalion is proud to be in charge of the Regulatory roadmap of the project, managing the submission of the clinical trial and the safety management plan. Stay tuned for more updates!
For further information, or if you need help for your HORIZON EU projects, contact us at: [email protected]
